Jonathan Rubin

Insider Reports History

Entity
Individual
Location
C/O Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD
Signature
/s/ Timothy C. Dec, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Rubin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SUPERNUS PHARMACEUTICALS, INC. SVP, Chief Medical Officer Common Stock 4.64K $135K $29.06 Feb 23, 2024 Direct
SUPERNUS PHARMACEUTICALS, INC. SVP, Chief Medical Officer Restricted Stock Unit 3.75K $109K $29.06 Feb 23, 2024 Direct
SUPERNUS PHARMACEUTICALS, INC. SVP, Chief Medical Officer Employee Stock Option (Right to Buy) 25K Feb 22, 2024 Direct
SUPERNUS PHARMACEUTICALS, INC. SVP, Chief Medical Officer Performance Share Unit 0 $27.66 Dec 22, 2023 Direct

Insider Reports Filed by Jonathan Rubin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 23, 2024 3 -$16.5K 4 Feb 27, 2024 SVP, Chief Medical Officer
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2024 5 -$8.47K 4 Feb 26, 2024 SVP, Chief Medical Officer
SUPN SUPERNUS PHARMACEUTICALS, INC. Dec 22, 2023 3 -$5.64K 4 Dec 26, 2023 Sr. VP, Chief Medical Officer
SUPN SUPERNUS PHARMACEUTICALS, INC. Dec 14, 2023 1 $0 4 Dec 18, 2023 SVP, Chief Medical Officer
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 23, 2023 2 $0 4 Feb 27, 2023 SVP, Chief Medical Officer
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2023 2 $0 4 Feb 24, 2023 SVP, Chief Medical Officer
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 16, 2023 2 $0 4 Feb 21, 2023 SVP, Chief Medical Officer
SUPN SUPERNUS PHARMACEUTICALS, INC. Jan 12, 2023 1 $0 4 Jan 17, 2023 Sr. VP, Chief Medical Officer
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2022 2 $0 4/A Feb 25, 2022 SVP, Chief Medical Officer